This study investigates the molecular mechanisms underlying ligand recognition, subtype selectivity, and activation of neuropeptide FF receptor 1 (NPFFR1)-a Gi/o-coupled receptor that responds to endogenous RF-amide peptides (RFRP-3 from pro-NPFFB, NPFF from pro-NPFFA) and regulates physiological... Read more
Medical News - Dec 13
Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) had its price objective hoisted by Oppenheimer from $190.00 to $250.00 in a report issued on Monday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. LGND has been the subject of several other resear... Read more
Defenseworld Net - Nov 04
